AQ22 revolutionizes e-pharmacies with an AI-powered virtual assistant, offering expert OTC medication advice and a novel sales channel.
Current Status
We are in the final stages of developing our MVP, with completion targeted for Q1, 2024. Concurrently, we are actively engaging with potential clients in the US for pilot version.
Problem or Opportunity
AQ22 addresses the challenge of providing expert health advice in e-pharmacies, which typically lack personalized guidance for over-the-counter (OTC) medication purchases. Our solution also introduces a new way for e-pharmacies to engage with customers, adding value to their shopping experience.
Solution (product or service)
Our AI-powered virtual pharmacist assistant offers accurate, real-time advice on OTC medications using advanced speech recognition and a custom-trained Language Learning Model. By integrating with e-pharmacy platforms, it enhances the online shopping experience, providing the kind of personalized guidance usually found in physical pharmacies, and creates a new, interactive sales channel using recommendation systems
Business model
We have adopted a revenue-sharing business model. We earn by taking a percentage from the increased basket size achieved through cross-selling, driven by our AI-powered virtual pharmacist assistant.
